Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Pfizer Limited    500680   INE182A01018

PFIZER LIMITED

(500680)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Pfizer : Malaysia to Buy 12.8 Million Doses of Pfizer's Covid-19 Vaccine

11/27/2020 | 06:02am EST

By Chester Tay

Malaysia has signed an agreement to procure a Covid-19 vaccine from Pfizer (Malaysia) Sdn. Bhd. to immunize 6.4 million of its citizens.

A planned 12.8 million doses of the vaccine will be supplied in four batches through 2021, Prime Minister Muhyiddin Yassin said Friday.

He said the government has also signed another agreement with the COVAX Facility to procure enough vaccines for 10% of the country's population.

The COVAX Facility is a mechanism established by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations and the World Health Organization to provide early access to Covid-19 candidate vaccines.

Mr. Muhyiddin said the government will also conduct the third phase of a clinical test for a Covid-19 vaccine developed by the Institute of Medical Biology Chinese Academy of Medical Sciences via a government-to-government initiative with China.

He said this clinical test in Malaysia involving 3,000 participants will commence in December, and assured that it will be conducted in compliance with the Ministry of Health's guidelines.

Write to Chester Tay at chester.tay@wsj.com

(END) Dow Jones Newswires

11-27-20 0601ET

Stocks mentioned in the article
ChangeLast1st jan.
PFIZER INC. -0.83% 36.5 Delayed Quote.-0.16%
PFIZER LIMITED -0.86% 5113.8 End-of-day quote.0.12%
All news about PFIZER LIMITED
01/13EXCLUSIVE : India wants Pfizer to do local study before approval - official
RE
01/03India's approval of homegrown vaccine criticised over lack of data
RE
01/03India approves AstraZeneca and local COVID vaccines, roll out seen soon
RE
01/02India's drugs experts approve AstraZeneca, local COVID vaccines
RE
01/01India drug regulator approves AstraZeneca COVID vaccine, country's first - so..
RE
01/01India drug regulator approves AstraZeneca COVID vaccine, country's first - so..
RE
2020Russia says Sputnik V coronavirus vaccine approved for use in Argentina
RE
2020India likely to approve AstraZeneca vaccine by next week- sources
RE
2020India seeks more data for emergency AstraZeneca shot approval
RE
2020Pfizer has sought emergency approval for COVID-19 vaccine in India -govt advi..
RE
More news
Financials
Sales 2021 22 580 M 309 M 309 M
Net income 2021 5 536 M 75,7 M 75,7 M
Net Debt 2021 - - -
P/E ratio 2021 42,3x
Yield 2021 6,32%
Capitalization 234 B 3 200 M 3 200 M
Capi. / Sales 2021 10,4x
Capi. / Sales 2022 9,41x
Nbr of Employees 2 489
Free-Float 33,3%
Chart PFIZER LIMITED
Duration : Period :
Pfizer Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 5 113,80 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Sridhar Subramaniam Managing Director & Executive Director
Rajendra Ambalal Shah Chairman
Deepak Rakheja Director-Global Commercial Operations
Milind Patil Chief Financial Officer & Executive Director
Navin Singhania Director-Business Technology
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER LIMITED0.12%3 228
JOHNSON & JOHNSON2.08%422 918
ROCHE HOLDING AG0.99%301 476
NOVARTIS AG-0.16%214 006
MERCK & CO., INC.0.45%207 893
PFIZER INC.-0.16%204 271